- Record: found
- Abstract: found
- Article: not found
Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.
R Ohno
1 ,
T Kobayashi ,
M Tanimoto ,
A Hiraoka ,
K Imai ,
N Asou ,
M Tomonaga ,
K Tsubaki ,
I Takahashi ,
Y Kodera
Jun 15 1993
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
It was assessed whether addition of vincristine (VCR) to remission induction therapy would increase the complete remission (CR) rate, and, secondarily, whether 12 courses of maintenance-intensification therapy would produce longer survival than 4 courses in adult acute myeloid leukemia (AML).